Rotigotine: Phase III data

In a double-blind, placebo-controlled, U.S. Phase III trial in 505 patients with moderate to severe RLS, SRZ's rotigotine patch met the co-primary

Read the full 222 word article

How to gain access

Continue reading with a
two-week free trial.